nodes	percent_of_prediction	percent_of_DWPC	metapath
Valrubicin—TOP2A—Cladribine—Abacavir—acquired immunodeficiency syndrome	0.00685	0.271	CbGdCrCtD
Valrubicin—TOP2A—Floxuridine—Stavudine—acquired immunodeficiency syndrome	0.00627	0.248	CbGdCrCtD
Valrubicin—TOP2A—Floxuridine—Zidovudine—acquired immunodeficiency syndrome	0.00627	0.248	CbGdCrCtD
Valrubicin—Malaise—Abacavir—acquired immunodeficiency syndrome	0.0032	0.00328	CcSEcCtD
Valrubicin—Myalgia—Nevirapine—acquired immunodeficiency syndrome	0.00318	0.00326	CcSEcCtD
Valrubicin—Hyperglycaemia—Ritonavir—acquired immunodeficiency syndrome	0.00315	0.00323	CcSEcCtD
Valrubicin—Discomfort—Nevirapine—acquired immunodeficiency syndrome	0.00314	0.00322	CcSEcCtD
Valrubicin—Oedema peripheral—Efavirenz—acquired immunodeficiency syndrome	0.00311	0.0032	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Didanosine—acquired immunodeficiency syndrome	0.00309	0.00317	CcSEcCtD
Valrubicin—Flatulence—Zidovudine—acquired immunodeficiency syndrome	0.00309	0.00317	CcSEcCtD
Valrubicin—TOP2A—Gemcitabine—Lamivudine—acquired immunodeficiency syndrome	0.00308	0.122	CbGdCrCtD
Valrubicin—Myalgia—Nelfinavir—acquired immunodeficiency syndrome	0.00308	0.00316	CcSEcCtD
Valrubicin—Myalgia—Stavudine—acquired immunodeficiency syndrome	0.00307	0.00315	CcSEcCtD
Valrubicin—Discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.00304	0.00312	CcSEcCtD
Valrubicin—Gastrointestinal pain—Amprenavir—acquired immunodeficiency syndrome	0.00304	0.00312	CcSEcCtD
Valrubicin—Hyperglycaemia—Saquinavir—acquired immunodeficiency syndrome	0.00303	0.00311	CcSEcCtD
Valrubicin—Back pain—Zidovudine—acquired immunodeficiency syndrome	0.00303	0.00311	CcSEcCtD
Valrubicin—Urinary tract infection—Ritonavir—acquired immunodeficiency syndrome	0.00303	0.00311	CcSEcCtD
Valrubicin—Myalgia—Abacavir—acquired immunodeficiency syndrome	0.00302	0.0031	CcSEcCtD
Valrubicin—Pneumonia—Saquinavir—acquired immunodeficiency syndrome	0.00302	0.00309	CcSEcCtD
Valrubicin—Dysuria—Lamivudine—acquired immunodeficiency syndrome	0.003	0.00308	CcSEcCtD
Valrubicin—Discomfort—Abacavir—acquired immunodeficiency syndrome	0.00299	0.00306	CcSEcCtD
Valrubicin—Oedema peripheral—Delavirdine—acquired immunodeficiency syndrome	0.00298	0.00306	CcSEcCtD
Valrubicin—Haematuria—Ritonavir—acquired immunodeficiency syndrome	0.00297	0.00305	CcSEcCtD
Valrubicin—Pollakiuria—Lamivudine—acquired immunodeficiency syndrome	0.00296	0.00304	CcSEcCtD
Valrubicin—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.00294	0.00301	CcSEcCtD
Valrubicin—Urinary tract infection—Saquinavir—acquired immunodeficiency syndrome	0.00292	0.00299	CcSEcCtD
Valrubicin—Ill-defined disorder—Zidovudine—acquired immunodeficiency syndrome	0.00291	0.00298	CcSEcCtD
Valrubicin—Anaemia—Zidovudine—acquired immunodeficiency syndrome	0.00289	0.00297	CcSEcCtD
Valrubicin—Hyperglycaemia—Lamivudine—acquired immunodeficiency syndrome	0.00289	0.00297	CcSEcCtD
Valrubicin—Flatulence—Indinavir—acquired immunodeficiency syndrome	0.00287	0.00294	CcSEcCtD
Valrubicin—TOP2A—Cytarabine—Lamivudine—acquired immunodeficiency syndrome	0.00283	0.112	CbGdCrCtD
Valrubicin—Malaise—Zidovudine—acquired immunodeficiency syndrome	0.00282	0.0029	CcSEcCtD
Valrubicin—Back pain—Indinavir—acquired immunodeficiency syndrome	0.00282	0.00289	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.00278	0.00285	CcSEcCtD
Valrubicin—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.00277	0.00284	CcSEcCtD
Valrubicin—Oedema peripheral—Ritonavir—acquired immunodeficiency syndrome	0.00276	0.00283	CcSEcCtD
Valrubicin—Flatulence—Efavirenz—acquired immunodeficiency syndrome	0.00271	0.00278	CcSEcCtD
Valrubicin—Ill-defined disorder—Indinavir—acquired immunodeficiency syndrome	0.0027	0.00277	CcSEcCtD
Valrubicin—Anaemia—Indinavir—acquired immunodeficiency syndrome	0.00269	0.00276	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.00269	0.00276	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.00268	0.00275	CcSEcCtD
Valrubicin—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.00268	0.00275	CcSEcCtD
Valrubicin—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.00268	0.00275	CcSEcCtD
Valrubicin—Chest pain—Zidovudine—acquired immunodeficiency syndrome	0.00267	0.00274	CcSEcCtD
Valrubicin—Myalgia—Zidovudine—acquired immunodeficiency syndrome	0.00267	0.00274	CcSEcCtD
Valrubicin—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.00267	0.00274	CcSEcCtD
Valrubicin—Back pain—Efavirenz—acquired immunodeficiency syndrome	0.00266	0.00273	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.00264	0.00271	CcSEcCtD
Valrubicin—Discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00263	0.0027	CcSEcCtD
Valrubicin—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00263	0.0027	CcSEcCtD
Valrubicin—Malaise—Indinavir—acquired immunodeficiency syndrome	0.00263	0.00269	CcSEcCtD
Valrubicin—Flatulence—Delavirdine—acquired immunodeficiency syndrome	0.00259	0.00266	CcSEcCtD
Valrubicin—Ill-defined disorder—Efavirenz—acquired immunodeficiency syndrome	0.00255	0.00262	CcSEcCtD
Valrubicin—Back pain—Delavirdine—acquired immunodeficiency syndrome	0.00255	0.00261	CcSEcCtD
Valrubicin—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.00254	0.00261	CcSEcCtD
Valrubicin—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00254	0.00261	CcSEcCtD
Valrubicin—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.00251	0.00258	CcSEcCtD
Valrubicin—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.00249	0.00256	CcSEcCtD
Valrubicin—Malaise—Efavirenz—acquired immunodeficiency syndrome	0.00248	0.00255	CcSEcCtD
Valrubicin—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.00248	0.00254	CcSEcCtD
Valrubicin—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.00248	0.00254	CcSEcCtD
Valrubicin—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.00245	0.00251	CcSEcCtD
Valrubicin—Ill-defined disorder—Delavirdine—acquired immunodeficiency syndrome	0.00244	0.00251	CcSEcCtD
Valrubicin—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.00243	0.0025	CcSEcCtD
Valrubicin—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.00243	0.00249	CcSEcCtD
Valrubicin—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00243	0.00249	CcSEcCtD
Valrubicin—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00241	0.00247	CcSEcCtD
Valrubicin—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.00241	0.00247	CcSEcCtD
Valrubicin—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00241	0.00247	CcSEcCtD
Valrubicin—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.0024	0.00247	CcSEcCtD
Valrubicin—Flatulence—Ritonavir—acquired immunodeficiency syndrome	0.0024	0.00246	CcSEcCtD
Valrubicin—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.0024	0.00246	CcSEcCtD
Valrubicin—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.00239	0.00245	CcSEcCtD
Valrubicin—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.00237	0.00244	CcSEcCtD
Valrubicin—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.00237	0.00243	CcSEcCtD
Valrubicin—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00236	0.00242	CcSEcCtD
Valrubicin—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.00236	0.00242	CcSEcCtD
Valrubicin—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.00234	0.0024	CcSEcCtD
Valrubicin—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.00234	0.0024	CcSEcCtD
Valrubicin—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00234	0.0024	CcSEcCtD
Valrubicin—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00234	0.0024	CcSEcCtD
Valrubicin—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00233	0.00239	CcSEcCtD
Valrubicin—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00233	0.00239	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00233	0.00239	CcSEcCtD
Valrubicin—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00233	0.00239	CcSEcCtD
Valrubicin—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00232	0.00239	CcSEcCtD
Valrubicin—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00232	0.00239	CcSEcCtD
Valrubicin—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00232	0.00238	CcSEcCtD
Valrubicin—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00231	0.00238	CcSEcCtD
Valrubicin—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.00231	0.00237	CcSEcCtD
Valrubicin—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00229	0.00235	CcSEcCtD
Valrubicin—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00229	0.00235	CcSEcCtD
Valrubicin—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.00227	0.00233	CcSEcCtD
Valrubicin—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.00226	0.00232	CcSEcCtD
Valrubicin—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.00225	0.00231	CcSEcCtD
Valrubicin—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.00224	0.0023	CcSEcCtD
Valrubicin—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.00224	0.0023	CcSEcCtD
Valrubicin—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00221	0.00227	CcSEcCtD
Valrubicin—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00221	0.00226	CcSEcCtD
Valrubicin—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.0022	0.00226	CcSEcCtD
Valrubicin—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.0022	0.00225	CcSEcCtD
Valrubicin—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00219	0.00224	CcSEcCtD
Valrubicin—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.00217	0.00223	CcSEcCtD
Valrubicin—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.00217	0.00222	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00217	0.00222	CcSEcCtD
Valrubicin—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.00216	0.00222	CcSEcCtD
Valrubicin—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00216	0.00221	CcSEcCtD
Valrubicin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00215	0.00221	CcSEcCtD
Valrubicin—Rash—Didanosine—acquired immunodeficiency syndrome	0.00214	0.00219	CcSEcCtD
Valrubicin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00213	0.00219	CcSEcCtD
Valrubicin—Headache—Didanosine—acquired immunodeficiency syndrome	0.00212	0.00218	CcSEcCtD
Valrubicin—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00212	0.00217	CcSEcCtD
Valrubicin—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.00211	0.00217	CcSEcCtD
Valrubicin—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00211	0.00216	CcSEcCtD
Valrubicin—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00211	0.00216	CcSEcCtD
Valrubicin—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00209	0.00214	CcSEcCtD
Valrubicin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00209	0.00214	CcSEcCtD
Valrubicin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00208	0.00214	CcSEcCtD
Valrubicin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00208	0.00213	CcSEcCtD
Valrubicin—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00208	0.00213	CcSEcCtD
Valrubicin—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.00207	0.00213	CcSEcCtD
Valrubicin—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00207	0.00213	CcSEcCtD
Valrubicin—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00207	0.00213	CcSEcCtD
Valrubicin—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.00207	0.00212	CcSEcCtD
Valrubicin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00205	0.0021	CcSEcCtD
Valrubicin—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00205	0.0021	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00205	0.0021	CcSEcCtD
Valrubicin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00202	0.00207	CcSEcCtD
Valrubicin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00202	0.00207	CcSEcCtD
Valrubicin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00202	0.00207	CcSEcCtD
Valrubicin—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.00202	0.00207	CcSEcCtD
Valrubicin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00201	0.00206	CcSEcCtD
Valrubicin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00201	0.00206	CcSEcCtD
Valrubicin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.002	0.00205	CcSEcCtD
Valrubicin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.002	0.00205	CcSEcCtD
Valrubicin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00198	0.00203	CcSEcCtD
Valrubicin—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00197	0.00202	CcSEcCtD
Valrubicin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00196	0.00201	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00196	0.00201	CcSEcCtD
Valrubicin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00195	0.002	CcSEcCtD
Valrubicin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00194	0.002	CcSEcCtD
Valrubicin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00194	0.00199	CcSEcCtD
Valrubicin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00194	0.00199	CcSEcCtD
Valrubicin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00192	0.00197	CcSEcCtD
Valrubicin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00192	0.00197	CcSEcCtD
Valrubicin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00192	0.00197	CcSEcCtD
Valrubicin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00191	0.00196	CcSEcCtD
Valrubicin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.0019	0.00195	CcSEcCtD
Valrubicin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.0019	0.00195	CcSEcCtD
Valrubicin—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00188	0.00193	CcSEcCtD
Valrubicin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00188	0.00193	CcSEcCtD
Valrubicin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00188	0.00193	CcSEcCtD
Valrubicin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00188	0.00192	CcSEcCtD
Valrubicin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00187	0.00192	CcSEcCtD
Valrubicin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00186	0.00191	CcSEcCtD
Valrubicin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00186	0.00191	CcSEcCtD
Valrubicin—Rash—Stavudine—acquired immunodeficiency syndrome	0.00185	0.0019	CcSEcCtD
Valrubicin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00185	0.0019	CcSEcCtD
Valrubicin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00185	0.0019	CcSEcCtD
Valrubicin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00185	0.0019	CcSEcCtD
Valrubicin—Headache—Stavudine—acquired immunodeficiency syndrome	0.00184	0.00189	CcSEcCtD
Valrubicin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00184	0.00189	CcSEcCtD
Valrubicin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00184	0.00188	CcSEcCtD
Valrubicin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00183	0.00188	CcSEcCtD
Valrubicin—Rash—Abacavir—acquired immunodeficiency syndrome	0.00183	0.00187	CcSEcCtD
Valrubicin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00183	0.00187	CcSEcCtD
Valrubicin—Headache—Abacavir—acquired immunodeficiency syndrome	0.00182	0.00186	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00181	0.00186	CcSEcCtD
Valrubicin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00181	0.00186	CcSEcCtD
Valrubicin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00181	0.00186	CcSEcCtD
Valrubicin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00178	0.00182	CcSEcCtD
Valrubicin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00178	0.00182	CcSEcCtD
Valrubicin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00177	0.00182	CcSEcCtD
Valrubicin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00176	0.0018	CcSEcCtD
Valrubicin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00175	0.0018	CcSEcCtD
Valrubicin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00175	0.00179	CcSEcCtD
Valrubicin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00175	0.00179	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00174	0.00179	CcSEcCtD
Valrubicin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00172	0.00177	CcSEcCtD
Valrubicin—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00171	0.00175	CcSEcCtD
Valrubicin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.0017	0.00174	CcSEcCtD
Valrubicin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.0017	0.00174	CcSEcCtD
Valrubicin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00169	0.00173	CcSEcCtD
Valrubicin—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00168	0.00173	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00166	0.00171	CcSEcCtD
Valrubicin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00164	0.00168	CcSEcCtD
Valrubicin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00163	0.00167	CcSEcCtD
Valrubicin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00163	0.00167	CcSEcCtD
Valrubicin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00163	0.00167	CcSEcCtD
Valrubicin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00161	0.00165	CcSEcCtD
Valrubicin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00161	0.00165	CcSEcCtD
Valrubicin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00161	0.00165	CcSEcCtD
Valrubicin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.0016	0.00164	CcSEcCtD
Valrubicin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00159	0.00163	CcSEcCtD
Valrubicin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00158	0.00162	CcSEcCtD
Valrubicin—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00157	0.00161	CcSEcCtD
Valrubicin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00157	0.00161	CcSEcCtD
Valrubicin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00157	0.00161	CcSEcCtD
Valrubicin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00156	0.0016	CcSEcCtD
Valrubicin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00154	0.00158	CcSEcCtD
Valrubicin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00154	0.00158	CcSEcCtD
Valrubicin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00152	0.00156	CcSEcCtD
Valrubicin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00152	0.00156	CcSEcCtD
Valrubicin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00151	0.00155	CcSEcCtD
Valrubicin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00151	0.00155	CcSEcCtD
Valrubicin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00151	0.00155	CcSEcCtD
Valrubicin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.0015	0.00154	CcSEcCtD
Valrubicin—Rash—Indinavir—acquired immunodeficiency syndrome	0.0015	0.00154	CcSEcCtD
Valrubicin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.0015	0.00154	CcSEcCtD
Valrubicin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00149	0.00153	CcSEcCtD
Valrubicin—Headache—Indinavir—acquired immunodeficiency syndrome	0.00149	0.00153	CcSEcCtD
Valrubicin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00149	0.00152	CcSEcCtD
Valrubicin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00147	0.00151	CcSEcCtD
Valrubicin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00144	0.00148	CcSEcCtD
Valrubicin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00144	0.00148	CcSEcCtD
Valrubicin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00143	0.00147	CcSEcCtD
Valrubicin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00143	0.00146	CcSEcCtD
Valrubicin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00142	0.00146	CcSEcCtD
Valrubicin—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00142	0.00145	CcSEcCtD
Valrubicin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00141	0.00145	CcSEcCtD
Valrubicin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00141	0.00145	CcSEcCtD
Valrubicin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00141	0.00144	CcSEcCtD
Valrubicin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00141	0.00144	CcSEcCtD
Valrubicin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00137	0.00141	CcSEcCtD
Valrubicin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00137	0.0014	CcSEcCtD
Valrubicin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00136	0.0014	CcSEcCtD
Valrubicin—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00136	0.00139	CcSEcCtD
Valrubicin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00135	0.00139	CcSEcCtD
Valrubicin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00135	0.00139	CcSEcCtD
Valrubicin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00135	0.00138	CcSEcCtD
Valrubicin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00133	0.00137	CcSEcCtD
Valrubicin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00131	0.00135	CcSEcCtD
Valrubicin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00131	0.00134	CcSEcCtD
Valrubicin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00131	0.00134	CcSEcCtD
Valrubicin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00129	0.00132	CcSEcCtD
Valrubicin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00128	0.00131	CcSEcCtD
Valrubicin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00126	0.0013	CcSEcCtD
Valrubicin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00126	0.0013	CcSEcCtD
Valrubicin—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00125	0.00129	CcSEcCtD
Valrubicin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00125	0.00128	CcSEcCtD
Valrubicin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00125	0.00128	CcSEcCtD
Valrubicin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00125	0.00128	CcSEcCtD
Valrubicin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00122	0.00125	CcSEcCtD
Valrubicin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00121	0.00124	CcSEcCtD
Valrubicin—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00121	0.00124	CcSEcCtD
Valrubicin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.0012	0.00124	CcSEcCtD
Valrubicin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.0012	0.00123	CcSEcCtD
Valrubicin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00118	0.00121	CcSEcCtD
Valrubicin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00116	0.00119	CcSEcCtD
Valrubicin—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00115	0.00118	CcSEcCtD
Valrubicin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00115	0.00118	CcSEcCtD
Valrubicin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00114	0.00117	CcSEcCtD
Valrubicin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00114	0.00117	CcSEcCtD
Valrubicin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00108	0.00111	CcSEcCtD
